# NMRA (Neumora Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Neumora Therapeutics, Inc. reported $95.05M in total assets and a net loss of $190.4M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/NMRA
- Markdown: https://convexityos.com/fundamentals/NMRA.md
- SEC CIK: 0001885522
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:50 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001885522&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$186.9M | Operating profit |
| Net Income | FY 2025 | -$190.4M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.01 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $85.65M | Total debt: $113.6M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Research & Development | $176.1M | $200.9M | $142.7M | $91.75M |
| Total Operating Expenses | $241.2M | $263.5M | $252.1M | $135.9M |
| **Operating Income** | -$241.2M | -$263.5M | -$252.1M | -$135.9M |
| **EBITDA** | -$240.9M | -$262.8M | -$251.4M | -$135.3M |
| Interest Income | $8.34M | $19.93M | -- | -- |
| Interest Expense | $2.01M | $0 | -- | -- |
| Income Before Tax | -$236.8M | -$243.6M | -$235.7M | -$130.9M |
| Income Tax Expense | $130K | $178K | $268K | -- |
| **Net Income** | -$236.9M | -$243.8M | -$235.9M | -$130.9M |
| Basic EPS | -$1.45 | -$1.53 | -$3.63 | -$4.81 |
| **Diluted EPS** | -$1.45 | -$1.53 | -$3.63 | -$4.81 |
| Basic Shares Outstanding | 163.4M | 159.4M | 65.0M | 27.2M |
| Diluted Shares Outstanding | 163.4M | 159.4M | 65.0M | 27.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $22.61M | $29.28M | $38.60M | $44.67M | $40.52M | $38.72M | $52.15M | $45.91M |
| Total Operating Expenses | $33.41M | $42.19M | $52.86M | $58.48M | $57.70M | $54.04M | $70.94M | $62.92M |
| **Operating Income** | -$33.41M | -$42.19M | -$52.86M | -$58.48M | -$57.70M | -$54.04M | -$70.94M | -$62.92M |
| **EBITDA** | -$33.41M | -$42.18M | -$52.86M | -$58.47M | -$57.68M | -$54.02M | -$70.78M | -$62.77M |
| Interest Income | $809K | $935K | $1.23M | $1.33M | $1.69M | $2.25M | $3.07M | -- |
| Interest Expense | $1.44M | $1.43M | $1.44M | $2.04M | $534K | $307K | $0 | -- |
| Income Before Tax | -$34.44M | -$43.08M | -$53.43M | -$59.45M | -$56.76M | -$52.71M | -$67.89M | -$58.82M |
| Income Tax Expense | $0 | $0 | $30K | $0 | $0 | $25K | $105K | -- |
| **Net Income** | -$34.44M | -$43.08M | -$53.46M | -$59.45M | -$56.76M | -$52.73M | -$67.99M | -$58.82M |
| Basic EPS | -$0.18 | -$0.23 | -$0.30 | -- | -$0.35 | -$0.33 | -$0.42 | -- |
| **Diluted EPS** | -$0.18 | -$0.23 | -$0.30 | -- | -$0.35 | -$0.33 | -$0.42 | -- |
| Basic Shares Outstanding | 187.9M | 185.2M | 179.9M | -- | 161.8M | 161.7M | 161.5M | -- |
| Diluted Shares Outstanding | 187.9M | 185.2M | 179.9M | -- | 161.8M | 161.7M | 161.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $182.5M | $142.1M | $374.0M | $240.9M |
| Short-Term Investments | -- | $165.4M | $79.94M | $130.9M |
| **Cash & Short-Term Investments** | $182.5M | $307.6M | $454.0M | $371.9M |
| **Total Current Assets** | $190.5M | $314.1M | $478.3M | $388.0M |
| Property, Plant & Equipment, Net | $40K | $1.14M | $1.79M | $2.41M |
| Long-Term Investments | -- | -- | $9.85M | $23.51M |
| Other Non-Current Assets | $93K | $0 | -- | $2.91M |
| **Total Non-Current Assets** | $510K | $2.92M | $17.92M | $38.28M |
| **Total Assets** | $191.0M | $317.0M | $496.2M | $426.2M |
| Accounts Payable | $3.38M | $3.31M | $337K | $7.15M |
| Short-Term Debt | $60.00M | -- | -- | -- |
| **Total Current Liabilities** | $32.45M | $29.89M | $25.11M | $23.70M |
| Long-Term Debt | $54.53M | $0 | -- | -- |
| **Total Non-Current Liabilities** | $54.73M | $22K | $2.01M | $5.70M |
| **Total Liabilities** | $87.18M | $29.91M | $27.12M | $29.40M |
| **Total Debt (incl. Leases)** | $115.0M | $1.85M | $5.23M | $8.44M |
| Common Stock | $17K | $16K | $16K | $3.0K |
| Retained Earnings | -$1.18B | -$947.2M | -$703.4M | -$467.5M |
| Accumulated Other Comp. Income | -- | $62K | -$76K | -$774K |
| **Total Stockholders' Equity** | $103.9M | $287.1M | $469.1M | -$446.9M |
| Total Equity | $103.9M | $287.1M | $469.1M | -$446.9M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $85.65M | $116.8M | $147.1M | $182.5M | $129.1M | $124.5M | $126.9M | $142.1M |
| Short-Term Investments | -- | -- | -- | -- | $42.45M | $93.06M | $122.5M | $165.4M |
| **Cash & Short-Term Investments** | $85.65M | $116.8M | $147.1M | $182.5M | $171.5M | $217.6M | $249.4M | $307.6M |
| **Total Current Assets** | $94.75M | $124.9M | $153.4M | $190.5M | $177.1M | $222.9M | $254.9M | $314.1M |
| Property, Plant & Equipment, Net | -- | $25K | $32K | $40K | $80K | $87K | $982K | $1.14M |
| Other Non-Current Assets | $66K | $53K | $53K | $93K | $197K | $298K | -- | $0 |
| **Total Non-Current Assets** | $300K | $375K | $443K | $510K | $751K | $916K | $1.88M | $2.92M |
| **Total Assets** | $95.05M | $125.2M | $153.9M | $191.0M | $177.8M | $223.8M | $256.7M | $317.0M |
| Accounts Payable | $1.95M | $4.15M | $5.06M | $3.38M | $549K | $644K | $1.05M | $3.31M |
| Short-Term Debt | $60.00M | $60.00M | $60.00M | $60.00M | $20.00M | $20.00M | -- | -- |
| **Total Current Liabilities** | $23.19M | $27.78M | $30.11M | $32.45M | $25.84M | $21.16M | $28.38M | $29.89M |
| Long-Term Debt | $53.30M | $52.91M | $52.96M | $54.53M | $19.56M | $19.45M | -- | $0 |
| **Total Non-Current Liabilities** | $53.30M | $52.95M | $53.08M | $54.73M | $19.83M | $19.79M | $0 | $22K |
| **Total Liabilities** | $76.50M | $80.73M | $83.20M | $87.18M | $45.67M | $40.95M | $28.38M | $29.91M |
| **Total Debt (incl. Leases)** | $113.6M | $113.3M | $113.4M | $115.0M | $40.09M | $39.96M | $938K | $1.85M |
| Common Stock | $19K | $19K | $18K | $17K | $16K | $16K | $16K | $16K |
| Retained Earnings | -$1.32B | -$1.28B | -$1.24B | -$1.18B | -$1.12B | -$1.07B | -$1.02B | -$947.2M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | $9.0K | -$15K | -$3.0K | $62K |
| **Total Stockholders' Equity** | $18.55M | $44.52M | $70.68M | $103.9M | $132.2M | $182.9M | $228.4M | $287.1M |
| Total Equity | $18.55M | $44.52M | $70.68M | $103.9M | $132.2M | $182.9M | $228.4M | $287.1M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$236.9M | -$243.8M | -$235.9M | -$130.9M |
| Depreciation & Amortization | $208K | $631K | $668K | $594K |
| Stock-Based Compensation | $29.88M | $39.99M | $17.24M | $8.30M |
| Change in Payables | $71K | $2.87M | -$581K | -$1.25M |
| **Operating Cash Flow** | -$206.4M | -$182.9M | -$163.3M | -$114.9M |
| Capital Expenditure | -- | -- | -$117K | -$511K |
| **Free Cash Flow** | -- | -- | -$163.4M | -$115.4M |
| Purchases of Investments | -$82.87M | -$312.2M | -$109.1M | -$226.4M |
| **Investing Cash Flow** | $168.5M | -$70.56M | $64.39M | -$168.0M |
| Common Stock Issued | -- | -- | $810K | -- |
| **Financing Cash Flow** | $77.09M | $21.60M | $231.9M | $115.7M |
| **Net Change in Cash** | $39.17M | -$231.9M | $133.0M | -$167.2M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$34.44M | -$43.08M | -$53.46M | -$59.45M | -$56.76M | -$52.73M | -$67.99M | -$58.82M |
| Depreciation & Amortization | $3.0K | $7.0K | $8.0K | $9.0K | $23K | $19K | $157K | $157K |
| Stock-Based Compensation | $6.14M | $7.18M | $7.41M | $7.41M | $5.98M | $7.17M | $9.32M | $9.90M |
| Change in Payables | -$2.19M | -$909K | $1.68M | $2.83M | -$96K | -$408K | -$2.25M | -$2.90M |
| **Operating Cash Flow** | -$33.44M | -$39.53M | -$46.40M | -$47.95M | -$46.63M | -$52.40M | -$59.45M | -$50.34M |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | -$38.48M | -$44.38M | -$106.9M |
| **Investing Cash Flow** | -$71K | $0 | $71K | $42.65M | $51.32M | $30.40M | $44.16M | -$98.80M |
| **Financing Cash Flow** | $2.33M | $9.29M | $10.88M | $58.77M | -$136K | $18.46M | $0 | $15.57M |
| **Net Change in Cash** | -$31.18M | -$30.24M | -$35.46M | $53.46M | $4.55M | -$3.55M | -$15.29M | -$133.6M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -228.1% | -84.9% | -50.3% | -- |
| Return on Assets (ROA) | -124.0% | -76.9% | -47.5% | -30.7% |
| Current Ratio | 5.87x | 10.51x | 19.05x | 16.37x |
| Quick Ratio | 5.62x | 10.29x | 18.08x | 15.69x |
| Debt to Equity | 1.11x | 0.01x | 0.01x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -1026.5% | -477.9% | -314.6% | -228.1% | -178.8% | -137.8% | -113.0% | -84.9% |
| Return on Assets (ROA) | -200.4% | -169.9% | -144.5% | -124.0% | -132.9% | -112.6% | -100.5% | -76.9% |
| Current Ratio | 4.08x | 4.50x | 5.09x | 5.87x | 6.85x | 10.54x | 8.98x | 10.51x |
| Quick Ratio | 3.69x | 4.21x | 4.88x | 5.62x | 6.64x | 10.28x | 8.78x | 10.29x |
| Debt to Equity | 6.12x | 2.54x | 1.60x | 1.11x | 0.30x | 0.22x | 0.00x | 0.01x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
